Trial Outcomes & Findings for Incorporating Nutrition, Vests, Education, and Strength Training in Bone Health (INVEST in Bone Health) (NCT NCT04076618)

NCT ID: NCT04076618

Last Updated: 2025-02-06

Results Overview

measured in mg/cm3 during computed tomography (CT) scan

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

150 participants

Primary outcome timeframe

12 months from baseline

Results posted on

2025-02-06

Participant Flow

Participant milestones

Participant milestones
Measure
Weight Loss Plus Vest
Vest: Weighted Vest worn \> or = 8 hours per day weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss Plus Resistance Exercise Training
Resistance Exercise Training: Structured exercise training 3 days a week weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss
weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Overall Study
STARTED
50
50
50
Overall Study
COMPLETED
45
45
43
Overall Study
NOT COMPLETED
5
5
7

Reasons for withdrawal

Reasons for withdrawal
Measure
Weight Loss Plus Vest
Vest: Weighted Vest worn \> or = 8 hours per day weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss Plus Resistance Exercise Training
Resistance Exercise Training: Structured exercise training 3 days a week weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss
weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Overall Study
Lost to Follow-up
2
1
3
Overall Study
Withdrawal by Subject
3
1
2
Overall Study
Relocated out of state
0
2
0
Overall Study
COVID concerns
0
1
0
Overall Study
Adverse Event
0
0
2

Baseline Characteristics

3 participants in the Weight Loss Plus Vest arm did not complete this task at baseline. 2 participants in the Resistance Exercise Training arm did not complete this task at baseline.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Weight Loss Plus Vest
n=50 Participants
Vest: Weighted Vest worn \> or = 8 hours per day weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss Plus Resistance Exercise Training
n=50 Participants
Resistance Exercise Training: Structured exercise training 3 days a week weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss
n=50 Participants
weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Total
n=150 Participants
Total of all reporting groups
Age, Continuous
66.9 years
STANDARD_DEVIATION 4.5 • n=50 Participants
66.4 years
STANDARD_DEVIATION 5.1 • n=50 Participants
65.9 years
STANDARD_DEVIATION 4.2 • n=50 Participants
66.4 years
STANDARD_DEVIATION 4.6 • n=150 Participants
Sex: Female, Male
Female
37 Participants
n=50 Participants
38 Participants
n=50 Participants
37 Participants
n=50 Participants
112 Participants
n=150 Participants
Sex: Female, Male
Male
13 Participants
n=50 Participants
12 Participants
n=50 Participants
13 Participants
n=50 Participants
38 Participants
n=150 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
n=50 Participants
1 Participants
n=50 Participants
1 Participants
n=50 Participants
3 Participants
n=150 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
49 Participants
n=50 Participants
49 Participants
n=50 Participants
49 Participants
n=50 Participants
147 Participants
n=150 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=50 Participants
0 Participants
n=50 Participants
0 Participants
n=50 Participants
0 Participants
n=150 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=50 Participants
0 Participants
n=50 Participants
0 Participants
n=50 Participants
0 Participants
n=150 Participants
Race (NIH/OMB)
Asian
0 Participants
n=50 Participants
0 Participants
n=50 Participants
0 Participants
n=50 Participants
0 Participants
n=150 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=50 Participants
0 Participants
n=50 Participants
0 Participants
n=50 Participants
0 Participants
n=150 Participants
Race (NIH/OMB)
Black or African American
16 Participants
n=50 Participants
15 Participants
n=50 Participants
12 Participants
n=50 Participants
43 Participants
n=150 Participants
Race (NIH/OMB)
White
33 Participants
n=50 Participants
35 Participants
n=50 Participants
35 Participants
n=50 Participants
103 Participants
n=150 Participants
Race (NIH/OMB)
More than one race
1 Participants
n=50 Participants
0 Participants
n=50 Participants
3 Participants
n=50 Participants
4 Participants
n=150 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=50 Participants
0 Participants
n=50 Participants
0 Participants
n=50 Participants
0 Participants
n=150 Participants
Body Mass Index (kg/m2)
93.6 Kilograms
STANDARD_DEVIATION 12.3 • n=50 Participants
92.7 Kilograms
STANDARD_DEVIATION 11.9 • n=50 Participants
92.3 Kilograms
STANDARD_DEVIATION 14.3 • n=50 Participants
92.9 Kilograms
STANDARD_DEVIATION 12.8 • n=150 Participants
Height
166.5 Centimeters
STANDARD_DEVIATION 8.5 • n=50 Participants
166.0 Centimeters
STANDARD_DEVIATION 8.0 • n=50 Participants
166.0 Centimeters
STANDARD_DEVIATION 8.8 • n=50 Participants
166.2 Centimeters
STANDARD_DEVIATION 8.4 • n=150 Participants
Body Mass Index
33.8 kg/m2
STANDARD_DEVIATION 3.7 • n=50 Participants
33.6 kg/m2
STANDARD_DEVIATION 3.0 • n=50 Participants
33.4 kg/m2
STANDARD_DEVIATION 3.3 • n=50 Participants
33.6 kg/m2
STANDARD_DEVIATION 3.3 • n=150 Participants
Education
High School Equivalent
13 Participants
n=50 Participants
7 Participants
n=50 Participants
8 Participants
n=50 Participants
28 Participants
n=150 Participants
Education
College
23 Participants
n=50 Participants
27 Participants
n=50 Participants
31 Participants
n=50 Participants
81 Participants
n=150 Participants
Education
Post Graduate
14 Participants
n=50 Participants
16 Participants
n=50 Participants
11 Participants
n=50 Participants
41 Participants
n=150 Participants
Comorbidities
Diabetes
5 Participants
n=50 Participants
1 Participants
n=50 Participants
6 Participants
n=50 Participants
12 Participants
n=150 Participants
Comorbidities
Cardiovascular Disease
4 Participants
n=50 Participants
6 Participants
n=50 Participants
6 Participants
n=50 Participants
16 Participants
n=150 Participants
Comorbidities
Arthritis/Joint Pain
39 Participants
n=50 Participants
29 Participants
n=50 Participants
36 Participants
n=50 Participants
104 Participants
n=150 Participants
Low Bone Mass
24 Participants
n=50 Participants
23 Participants
n=50 Participants
26 Participants
n=50 Participants
73 Participants
n=150 Participants
Total Physical Activity
1941 Kilocalories Per Week
n=50 Participants
2144 Kilocalories Per Week
n=50 Participants
2042 Kilocalories Per Week
n=50 Participants
2029 Kilocalories Per Week
n=150 Participants
Fast Gait Speed
1.3 Meters Per Second
STANDARD_DEVIATION 0.2 • n=47 Participants • 3 participants in the Weight Loss Plus Vest arm did not complete this task at baseline. 2 participants in the Resistance Exercise Training arm did not complete this task at baseline.
1.3 Meters Per Second
STANDARD_DEVIATION 0.2 • n=48 Participants • 3 participants in the Weight Loss Plus Vest arm did not complete this task at baseline. 2 participants in the Resistance Exercise Training arm did not complete this task at baseline.
1.3 Meters Per Second
STANDARD_DEVIATION 0.1 • n=50 Participants • 3 participants in the Weight Loss Plus Vest arm did not complete this task at baseline. 2 participants in the Resistance Exercise Training arm did not complete this task at baseline.
1.3 Meters Per Second
STANDARD_DEVIATION 0.2 • n=145 Participants • 3 participants in the Weight Loss Plus Vest arm did not complete this task at baseline. 2 participants in the Resistance Exercise Training arm did not complete this task at baseline.
Moderate Intensity Physical Activity
30 Minutes Per Week
n=50 Participants
45 Minutes Per Week
n=50 Participants
0 Minutes Per Week
n=50 Participants
30 Minutes Per Week
n=150 Participants

PRIMARY outcome

Timeframe: 12 months from baseline

Population: 6 participants in Weight Loss Plus Vest arm did not complete a CT scan. 5 participants in Weight Loss Plus Resistance Exercise Training arm did not complete a scan. 7 participants in Weight Loss arm did not complete scan.

measured in mg/cm3 during computed tomography (CT) scan

Outcome measures

Outcome measures
Measure
Weight Loss Plus Vest
n=44 Participants
Vest: Weighted Vest worn \> or = 8 hours per day weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss Plus Resistance Exercise Training
n=45 Participants
Resistance Exercise Training: Structured exercise training 3 days a week weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss
n=43 Participants
weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Change in Total Hip Trabecular Volumetric Bone Mineral Density (vBMD)
-0.002 mg/cm3
Interval -0.003 to -0.001
-0.002 mg/cm3
Interval -0.003 to -0.001
-0.003 mg/cm3
Interval -0.003 to -0.002

SECONDARY outcome

Timeframe: 6 months from baseline

Population: 4 participants in Weight Loss Plus Vest arm did not complete a CT scan. 4 participants in Weight Loss Plus Resistance Exercise Training arm did not complete a scan. 6 participants in Weight Loss arm did not complete scan.

measured in mg/cm3 during computed tomography (CT) scan

Outcome measures

Outcome measures
Measure
Weight Loss Plus Vest
n=46 Participants
Vest: Weighted Vest worn \> or = 8 hours per day weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss Plus Resistance Exercise Training
n=46 Participants
Resistance Exercise Training: Structured exercise training 3 days a week weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss
n=44 Participants
weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Change in Total Hip Trabecular Volumetric Bone Mineral Density (vBMD)
-0.001 mg/cm3
Interval -0.001 to 0.0
-0.000 mg/cm3
Interval -0.001 to 0.001
-0.000 mg/cm3
Interval -0.001 to 0.0

SECONDARY outcome

Timeframe: 6 months from baseline

Population: 4 participants in Weight Loss Plus Vest arm did not complete a CT scan. 4 participants in Weight Loss Plus Resistance Exercise Training arm did not complete a scan. 6 participants in Weight Loss arm did not complete scan.

measured in mg/cm3 during computed tomography (CT) scan

Outcome measures

Outcome measures
Measure
Weight Loss Plus Vest
n=46 Participants
Vest: Weighted Vest worn \> or = 8 hours per day weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss Plus Resistance Exercise Training
n=46 Participants
Resistance Exercise Training: Structured exercise training 3 days a week weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss
n=44 Participants
weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Change in Femoral Neck Volumetric Bone Mineral Density (vBMD)
-0.001 mg/cm3
Interval -0.003 to 0.001
-0.001 mg/cm3
Interval -0.003 to 0.001
-0.001 mg/cm3
Interval -0.002 to 0.001

SECONDARY outcome

Timeframe: 12 months from baseline

Population: 6 participants in Weight Loss Plus Vest arm did not complete a CT scan. 5 participants in Weight Loss Plus Resistance Exercise Training arm did not complete a scan. 7 participants in Weight Loss arm did not complete scan.

measured in mg/cm3 during computed tomography (CT) scan

Outcome measures

Outcome measures
Measure
Weight Loss Plus Vest
n=44 Participants
Vest: Weighted Vest worn \> or = 8 hours per day weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss Plus Resistance Exercise Training
n=45 Participants
Resistance Exercise Training: Structured exercise training 3 days a week weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss
n=43 Participants
weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Change in Femoral Neck Volumetric Bone Mineral Density (vBMD)
-0.002 mg/cm3
Interval -0.004 to 0.001
-0.003 mg/cm3
Interval -0.005 to 0.0
-0.004 mg/cm3
Interval -0.007 to -0.002

SECONDARY outcome

Timeframe: 6 months from baseline

Population: 3 participants in Weight Loss Plus Vest arm did not complete the scan. 4 participants in Weight Loss Plus Resistance Exercise Training arm did not complete the scan. 5 participants in the Weight Loss arm did not complete the scan.

measured in mg/cm3 during computed tomography (CT) scan

Outcome measures

Outcome measures
Measure
Weight Loss Plus Vest
n=47 Participants
Vest: Weighted Vest worn \> or = 8 hours per day weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss Plus Resistance Exercise Training
n=46 Participants
Resistance Exercise Training: Structured exercise training 3 days a week weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss
n=45 Participants
weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Change in Lumbar Spine Volumetric Bone Mineral Density (vBMD)
0.001 mg/cm3
Interval -0.002 to 0.005
0.005 mg/cm3
Interval 0.001 to 0.008
0.005 mg/cm3
Interval 0.002 to 0.008

SECONDARY outcome

Timeframe: 12 months from baseline

Population: 5 participants in Weight Loss Plus Vest arm did not complete the scan. 5 participants in Weight Loss Plus Resistance Exercise Training arm did not complete the scan. 7 participants in the Weight Loss arm did not complete the scan.

measured in mg/cm3 during computed tomography (CT) scan

Outcome measures

Outcome measures
Measure
Weight Loss Plus Vest
n=45 Participants
Vest: Weighted Vest worn \> or = 8 hours per day weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss Plus Resistance Exercise Training
n=45 Participants
Resistance Exercise Training: Structured exercise training 3 days a week weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss
n=43 Participants
weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Change in Lumbar Spine Volumetric Bone Mineral Density (vBMD)
-0.000 mg/cm3
Interval -0.002 to 0.002
0.003 mg/cm3
Interval 0.001 to 0.005
0.000 mg/cm3
Interval -0.002 to 0.002

SECONDARY outcome

Timeframe: 6 months from baseline

Population: 3 participants in Weight Loss Plus Vest arm did not complete DXA scan. 3 participants in Weight Loss Plus Resistance Exercise Training Arm did not complete DXA scan. 5 participants in Weight Loss arm did not complete DXA scan.

measurement taken during dual energy x-ray absorptiometry (DXA) scan; Trabecular Bone Score is a measure of bone architecture that has been shown to be an independent risk factor for fracture. The measure is unitless, and ranges from 1.0-1.6, where an elevated TBS greater than or equal to 1.3 appears to represent strong, fracture-resistant bone architecture, while a low TBS less than or equal to 1.2 reflects weak, fracture-prone bone architecture.

Outcome measures

Outcome measures
Measure
Weight Loss Plus Vest
n=47 Participants
Vest: Weighted Vest worn \> or = 8 hours per day weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss Plus Resistance Exercise Training
n=47 Participants
Resistance Exercise Training: Structured exercise training 3 days a week weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss
n=45 Participants
weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Change in Trabecular Bone Score (TBS)
0.020 score on a scale
Interval 0.002 to 0.039
0.037 score on a scale
Interval 0.018 to 0.056
0.017 score on a scale
Interval -0.002 to 0.035

SECONDARY outcome

Timeframe: 12 months from baseline

Population: 5 participants in Weight Loss Plus Vest arm did not complete DXA scan. 5 participants in Weight Loss Plus Resistance Exercise Training Arm did not complete DXA scan. 7 participants in Weight Loss arm did not complete DXA scan.

measurement taken during dual energy x-ray absorptiometry (DXA) scan; Trabecular Bone Score is a measure of bone architecture that has been shown to be an independent risk factor for fracture. The measure is unitless, and ranges from 1.0-1.6, where an elevated TBS greater than or equal to 1.3 appears to represent strong, fracture-resistant bone architecture, while a low TBS less than or equal to 1.2 reflects weak, fracture-prone bone architecture.

Outcome measures

Outcome measures
Measure
Weight Loss Plus Vest
n=45 Participants
Vest: Weighted Vest worn \> or = 8 hours per day weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss Plus Resistance Exercise Training
n=45 Participants
Resistance Exercise Training: Structured exercise training 3 days a week weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss
n=43 Participants
weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Change in Trabecular Bone Score (TBS)
0.014 score on a scale
Interval -0.005 to 0.034
0.037 score on a scale
Interval 0.017 to 0.057
0.017 score on a scale
Interval -0.003 to 0.037

SECONDARY outcome

Timeframe: 6 months from baseline

Population: 3 participants in Weight Loss Plus Vest did not complete DXA scan. 3 participants in Weight Loss Plus Resistance Exercise Training arm did not complete DXA scan. 5 participants in Weight Loss arm did not complete DXA scan.

measured in g/cm2 during dual energy x-ray absorptiometry (DXA) scan

Outcome measures

Outcome measures
Measure
Weight Loss Plus Vest
n=47 Participants
Vest: Weighted Vest worn \> or = 8 hours per day weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss Plus Resistance Exercise Training
n=47 Participants
Resistance Exercise Training: Structured exercise training 3 days a week weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss
n=45 Participants
weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Change in Total Hip Areal Bone Mineral Density (aBMD)
-0.006 g/cm2
Interval -0.013 to 0.001
-0.008 g/cm2
Interval -0.015 to -0.001
-0.008 g/cm2
Interval -0.015 to -0.001

SECONDARY outcome

Timeframe: 12 months from baseline

Population: 5 participants in Weight Loss Plus Vest did not complete DXA scan. 5 participants in Weight Loss Plus Resistance Exercise Training arm did not complete DXA scan. 7 participants in Weight Loss arm did not complete DXA scan.

measured in g/cm2 during dual energy x-ray absorptiometry (DXA) scan

Outcome measures

Outcome measures
Measure
Weight Loss Plus Vest
n=45 Participants
Vest: Weighted Vest worn \> or = 8 hours per day weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss Plus Resistance Exercise Training
n=45 Participants
Resistance Exercise Training: Structured exercise training 3 days a week weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss
n=43 Participants
weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Change in Total Hip Areal Bone Mineral Density (aBMD)
-0.015 g/cm2
Interval -0.023 to -0.007
-0.016 g/cm2
Interval -0.024 to -0.008
-0.017 g/cm2
Interval -0.025 to -0.009

SECONDARY outcome

Timeframe: 6 months from baseline

Population: 3 participants in Weight Loss Plus Vest arm did not complete DXA scan. 3 participants in Weight Loss Plus Resistance Exercise Training arm did not complete DXA scan. 5 participants in Weight Loss arm did not complete DXA scan.

measured in g/cm2 during dual energy x-ray absorptiometry (DXA) scan

Outcome measures

Outcome measures
Measure
Weight Loss Plus Vest
n=47 Participants
Vest: Weighted Vest worn \> or = 8 hours per day weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss Plus Resistance Exercise Training
n=47 Participants
Resistance Exercise Training: Structured exercise training 3 days a week weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss
n=45 Participants
weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Change in Femoral Neck Areal Bone Mineral Density (aBMD)
-0.000 g/cm2
Interval -0.011 to 0.01
0.004 g/cm2
Interval -0.007 to 0.014
0.004 g/cm2
Interval -0.007 to 0.015

SECONDARY outcome

Timeframe: 12 months from baseline

Population: 5 participants in Weight Loss Plus Vest arm did not complete DXA scan. 5 participants in Weight Loss Plus Resistance Exercise Training arm did not complete DXA scan. 7 participants in Weight Loss arm did not complete DXA scan.

measured in g/cm2 during dual energy x-ray absorptiometry (DXA) scan

Outcome measures

Outcome measures
Measure
Weight Loss Plus Vest
n=45 Participants
Vest: Weighted Vest worn \> or = 8 hours per day weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss Plus Resistance Exercise Training
n=45 Participants
Resistance Exercise Training: Structured exercise training 3 days a week weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss
n=43 Participants
weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Change in Femoral Neck Areal Bone Mineral Density (aBMD)
-0.006 g/cm2
Interval -0.017 to 0.005
-0.004 g/cm2
Interval -0.015 to 0.008
-0.005 g/cm2
Interval -0.016 to 0.007

SECONDARY outcome

Timeframe: 6 months from baseline

Population: 3 participants in the Weight Loss Plus Vest arm did not complete DXA scan. 3 participants in the Weight Loss Plus Resistance Exercise Training arm did not complete DXA scan. 5 participants in the Weight Loss arm did not complete DXA scan.

measured in g/cm2 during dual energy x-ray absorptiometry (DXA) scan

Outcome measures

Outcome measures
Measure
Weight Loss Plus Vest
n=47 Participants
Vest: Weighted Vest worn \> or = 8 hours per day weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss Plus Resistance Exercise Training
n=47 Participants
Resistance Exercise Training: Structured exercise training 3 days a week weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss
n=45 Participants
weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Change in Distal Radius Areal Bone Mineral Density (aBMD)
-0.009 g/cm2
Interval -0.018 to 0.0
-0.008 g/cm2
Interval -0.018 to 0.001
-0.007 g/cm2
Interval -0.016 to 0.002

SECONDARY outcome

Timeframe: 12 months from baseline

Population: 5 participants in the Weight Loss Plus Vest arm did not complete DXA scan. 5 participants in the Weight Loss Plus Resistance Exercise Training arm did not complete DXA scan. 7 participants in the Weight Loss arm did not complete DXA scan.

measured in g/cm2 during dual energy x-ray absorptiometry (DXA) scan

Outcome measures

Outcome measures
Measure
Weight Loss Plus Vest
n=45 Participants
Vest: Weighted Vest worn \> or = 8 hours per day weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss Plus Resistance Exercise Training
n=45 Participants
Resistance Exercise Training: Structured exercise training 3 days a week weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss
n=43 Participants
weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Change in Distal Radius Areal Bone Mineral Density (aBMD)
-0.013 g/cm2
Interval -0.022 to -0.003
-0.007 g/cm2
Interval -0.017 to 0.003
-0.013 g/cm2
Interval -0.022 to -0.003

SECONDARY outcome

Timeframe: 6 months from baseline

Population: 3 participants in Weight Loss Plus Vest arm did not complete DXA scan. 3 participants in Weight Loss Plus Resistance Exercise Training arm did not complete DXA scan. 5 participants in Weight Loss arm did not complete DXA scan.

measured in g/cm2 during dual energy x-ray absorptiometry (DXA) scan

Outcome measures

Outcome measures
Measure
Weight Loss Plus Vest
n=47 Participants
Vest: Weighted Vest worn \> or = 8 hours per day weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss Plus Resistance Exercise Training
n=47 Participants
Resistance Exercise Training: Structured exercise training 3 days a week weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss
n=45 Participants
weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Change in Lumbar Spine Areal Bone Mineral Density (aBMD)
0.003 g/cm2
Interval -0.011 to 0.017
0.015 g/cm2
Interval 0.0 to 0.03
0.016 g/cm2
Interval 0.001 to 0.03

SECONDARY outcome

Timeframe: 12 months from baseline

Population: 5 participants in Weight Loss Plus Vest arm did not complete DXA scan. 5 participants in Weight Loss Plus Resistance Exercise Training arm did not complete DXA scan. 7 participants in Weight Loss arm did not complete DXA scan.

measured in g/cm2 during dual energy x-ray absorptiometry (DXA) scan

Outcome measures

Outcome measures
Measure
Weight Loss Plus Vest
n=45 Participants
Vest: Weighted Vest worn \> or = 8 hours per day weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss Plus Resistance Exercise Training
n=45 Participants
Resistance Exercise Training: Structured exercise training 3 days a week weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss
n=43 Participants
weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Change in Lumbar Spine Areal Bone Mineral Density (aBMD)
0.006 g/cm2
Interval -0.012 to 0.023
0.011 g/cm2
Interval -0.007 to 0.028
0.010 g/cm2
Interval -0.008 to 0.027

SECONDARY outcome

Timeframe: 6 months from baseline

Population: 3 participants in Weight Loss Plus Vest arm did not complete DXA scan. 3 participants in Weight Loss Plus Resistance Exercise Training arm did not complete DXA scan. 5 participants in Weight Loss arm did not complete DXA scan.

measurement taken during dual energy x-ray absorptiometry (DXA) scan

Outcome measures

Outcome measures
Measure
Weight Loss Plus Vest
n=47 Participants
Vest: Weighted Vest worn \> or = 8 hours per day weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss Plus Resistance Exercise Training
n=47 Participants
Resistance Exercise Training: Structured exercise training 3 days a week weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss
n=45 Participants
weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Change in Total Body Fat Mass (kg)
-7.8 kg
Interval -9.1 to -6.5
-8.8 kg
Interval -10.2 to -7.5
-7.8 kg
Interval -9.2 to -6.5

SECONDARY outcome

Timeframe: 12 months from baseline

Population: 5 participants in Weight Loss Plus Vest arm did not complete DXA scan. 5 participants in Weight Loss Plus Resistance Exercise Training arm did not complete DXA scan. 7 participants in Weight Loss arm did not complete DXA scan.

measurement taken during dual energy x-ray absorptiometry (DXA) scan

Outcome measures

Outcome measures
Measure
Weight Loss Plus Vest
n=45 Participants
Vest: Weighted Vest worn \> or = 8 hours per day weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss Plus Resistance Exercise Training
n=45 Participants
Resistance Exercise Training: Structured exercise training 3 days a week weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss
n=43 Participants
weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Change in Total Body Fat Mass (kg)
-7.3 kg
Interval -8.9 to -5.7
-10.0 kg
Interval -11.6 to -8.3
-7.7 kg
Interval -9.4 to -6.0

SECONDARY outcome

Timeframe: 6 months from baseline

Population: 3 participants in Weight Loss Plus Vest arm did not complete DXA scan. 3 participants in Weight Loss Plus Resistance Exercise Training arm did not complete DXA scan. 5 participants in Weight Loss arm did not complete DXA scan.

measurement taken during dual energy x-ray absorptiometry (DXA)

Outcome measures

Outcome measures
Measure
Weight Loss Plus Vest
n=47 Participants
Vest: Weighted Vest worn \> or = 8 hours per day weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss Plus Resistance Exercise Training
n=47 Participants
Resistance Exercise Training: Structured exercise training 3 days a week weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss
n=45 Participants
weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Change in Total Body Lean Mass (kg)
-0.5 kg
Interval -1.1 to 0.0
-0.8 kg
Interval -1.4 to -0.2
-0.7 kg
Interval -1.2 to -0.1

SECONDARY outcome

Timeframe: 12 months from baseline

Population: 5 participants in Weight Loss Plus Vest arm did not complete DXA scan. 5 participants in Weight Loss Plus Resistance Exercise Training arm did not complete DXA scan. 7 participants in Weight Loss arm did not complete DXA scan.

measurement taken during dual energy x-ray absorptiometry (DXA)

Outcome measures

Outcome measures
Measure
Weight Loss Plus Vest
n=45 Participants
Vest: Weighted Vest worn \> or = 8 hours per day weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss Plus Resistance Exercise Training
n=45 Participants
Resistance Exercise Training: Structured exercise training 3 days a week weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss
n=43 Participants
weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Change in Total Body Lean Mass (kg)
-0.7 kg
Interval -1.3 to -0.2
-0.9 kg
Interval -1.4 to -0.3
-0.9 kg
Interval -1.5 to -0.4

OTHER_PRE_SPECIFIED outcome

Timeframe: 12 months from baseline

measurement taken during computed tomography (CT) scan

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 12 months from baseline

measurement taken during computed tomography (CT) scan

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 12 months from baseline

measurement taken during computed tomography (CT) scan

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 12 months from baseline

measurement taken during computed tomography (CT) scan

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 12 months from baseline

measurement taken during computed tomography (CT) scan

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 12 months from baseline

measurement taken during computed tomography (CT) scan

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 12 months from baseline

measurement taken during computed tomography (CT) scan

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 12 months from baseline

measurement taken during computed tomography (CT) scan

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 12 months from baseline

Biomarkers of bone turnover measured via blood specimen

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 12 months from baseline

Biomarkers of bone turnover measured via blood specimen

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 12 months from baseline

measurement taken via urine sample

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 12 months from baseline

measured in m/s during the 400 meter walk test

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 12 months from baseline

The SPPB is a measure of balance, walking speed, and ability to stand from a chair. It provides a global measure of overall physical function and is a good predictor of future disability, institutionalization, and mortality in older persons. The SPPB score is calculated by assigning each of the test measures (balance, walking speed, and chair stands) a score from 0 (unable to do) to 4 (best) and then adding these scores together for a total score ranging from 0 to 12. An SPPB score less than 10 identifies persons at higher risk for mobility disability.

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 12 months from baseline

measured in seconds to assess physical performance; measures the time the participant takes to stand up from a standard chair, walk 3 meters, turn, walk back to the chair, and sit down again.

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 12 months from baseline

measured in seconds using the participant's fastest time achieved to climb a 12 step staircase in two trials.

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 12 months from baseline

measured using an isokinetic dynamometer with the participant sitting and the hips and knee flexed at 90°. Participants will be asked to extend the knee and push as hard as possible against the resistance pad. Strength is expressed as peak torque (Nm)

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 12 months from baseline

measured twice in each hand to the nearest two kg using an isometric Jamar Hydraulic Hand Dynamometer with the mean value from the stronger hand used

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 12 months from baseline

measured using the Montreal Cognitive Assessment (MOCA) with scores ranging from 0-30, with a score of 26 and higher generally considered normal.

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 12 months from baseline

measured using the Pittsburgh Fatigability scale, which is a 10-item questionnaire that assesses fatigability, or the rate at which a person experiences mental or physical fatigue in the context of a standardized task. The scale ranges from 0-5, where those who exhibit more fatigability, score of 5, are more likely to limit activities of daily living and to reduce exertion during physical activities.

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 12 months from baseline

measured using The Patient-Reported Outcomes Measurement Information System (PROMIS) instrument is an 8-item short-form that assesses pain and fatigue over the past 7 days. The scale ranges from 1-5, with higher scores indicated the presence of pain and fatigue.

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 12 months from baseline

The CHAMPS questionnaire is a 40-43-item tool that assesses weekly frequency and duration of a variety of lifestyle physical activities that are appropriate for older adults. The purpose of this questionnaire is to evaluate the effectiveness of interventions to increase lifestyle physical activity among older adults. Physical activities are given a METS score, ranging from 2.0-7.0, where activities with an activities of moderate intensity (METS) score of 3.0 or higher, are considered moderate intensity.

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 6 months from baseline

measured in Newtons via force-sensing insoles to assess overall limb loading and to determine if participants receive enough loading to prevent bone loss from resistance training and weighted vest use when compared to weight loss alone.

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 6 months from baseline

overall satisfaction measured by a scale from 1-5 with a higher score indicating greater satisfaction

Outcome measures

Outcome data not reported

Adverse Events

Weight Loss Plus Vest

Serious events: 3 serious events
Other events: 23 other events
Deaths: 0 deaths

Weight Loss Plus Resistance Exercise Training

Serious events: 1 serious events
Other events: 22 other events
Deaths: 0 deaths

Weight Loss

Serious events: 2 serious events
Other events: 20 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Weight Loss Plus Vest
n=50 participants at risk
Vest: Weighted Vest worn \> or = 8 hours per day weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss Plus Resistance Exercise Training
n=50 participants at risk
Resistance Exercise Training: Structured exercise training 3 days a week weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss
n=50 participants at risk
weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Renal and urinary disorders
Prostate transurethral resection
0.00%
0/50 • Baseline through Month 12
0.00%
0/50 • Baseline through Month 12
2.0%
1/50 • Number of events 1 • Baseline through Month 12
Eye disorders
Retinal detachment
2.0%
1/50 • Number of events 1 • Baseline through Month 12
0.00%
0/50 • Baseline through Month 12
0.00%
0/50 • Baseline through Month 12
Gastrointestinal disorders
Small bowel obstruction
2.0%
1/50 • Number of events 1 • Baseline through Month 12
0.00%
0/50 • Baseline through Month 12
2.0%
1/50 • Number of events 1 • Baseline through Month 12
Musculoskeletal and connective tissue disorders
Back pain
0.00%
0/50 • Baseline through Month 12
2.0%
1/50 • Number of events 1 • Baseline through Month 12
0.00%
0/50 • Baseline through Month 12
Social circumstances
Motor vehicle accident
2.0%
1/50 • Number of events 1 • Baseline through Month 12
0.00%
0/50 • Baseline through Month 12
0.00%
0/50 • Baseline through Month 12

Other adverse events

Other adverse events
Measure
Weight Loss Plus Vest
n=50 participants at risk
Vest: Weighted Vest worn \> or = 8 hours per day weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss Plus Resistance Exercise Training
n=50 participants at risk
Resistance Exercise Training: Structured exercise training 3 days a week weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Weight Loss
n=50 participants at risk
weight loss program: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Social circumstances
Fall
24.0%
12/50 • Number of events 14 • Baseline through Month 12
12.0%
6/50 • Number of events 7 • Baseline through Month 12
20.0%
10/50 • Number of events 10 • Baseline through Month 12
Respiratory, thoracic and mediastinal disorders
COVID-19
10.0%
5/50 • Number of events 5 • Baseline through Month 12
20.0%
10/50 • Number of events 11 • Baseline through Month 12
10.0%
5/50 • Number of events 5 • Baseline through Month 12
Infections and infestations
Sinusitis
4.0%
2/50 • Number of events 2 • Baseline through Month 12
4.0%
2/50 • Number of events 2 • Baseline through Month 12
12.0%
6/50 • Number of events 7 • Baseline through Month 12
Musculoskeletal and connective tissue disorders
Back pain
12.0%
6/50 • Number of events 6 • Baseline through Month 12
6.0%
3/50 • Number of events 3 • Baseline through Month 12
2.0%
1/50 • Number of events 1 • Baseline through Month 12
Renal and urinary disorders
Urinary tract infection
4.0%
2/50 • Number of events 2 • Baseline through Month 12
6.0%
3/50 • Number of events 4 • Baseline through Month 12
2.0%
1/50 • Number of events 1 • Baseline through Month 12
Musculoskeletal and connective tissue disorders
Shoulder pain
6.0%
3/50 • Number of events 3 • Baseline through Month 12
4.0%
2/50 • Number of events 2 • Baseline through Month 12
2.0%
1/50 • Number of events 1 • Baseline through Month 12
Musculoskeletal and connective tissue disorders
Knee pain
2.0%
1/50 • Number of events 1 • Baseline through Month 12
6.0%
3/50 • Number of events 3 • Baseline through Month 12
0.00%
0/50 • Baseline through Month 12

Additional Information

Kristen Beavers, PhD, MPH, RD

Wake Forest University School of Medicine

Phone: 336-758-5855

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place